Regenerative medicine for cardiovascular disorders-new milestones: adult stem cells

Artificial Organs
A Ruchan AkarUmit Ozyurda

Abstract

Cardiovascular disorders are the leading causes of mortality and morbidity in the developed world. Cell-based modalities have received considerable scientific attention over the last decade for their potential use in this clinical arena. This review was intended as a brief overview on the subject of therapeutic potential of adult stem cells in cardiovascular medicine with basic science findings and the current status of clinical applications. The historical perspective and basic concepts are reviewed and a description of current applications and potential adverse effects in cardiovascular medicine is given. Future improvements on cell-based therapies will likely provide remarkable improvement in survival and quality of life for millions of patients with cardiovascular disorders.

References

Jan 1, 1992·Cell Transplantation·D MarelliR C Chiu
Jun 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·B S AllenS Feinstein
Apr 1, 1995·Journal of Cardiothoracic and Vascular Anesthesia·J WinkelmannB K Lee
Dec 8, 1994·The New England Journal of Medicine·G W Dec, V Fuster
Dec 1, 1996·The Journal of Clinical Investigation·C E MurryS D Hauschka
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·J KajsturaP Anversa
Mar 13, 1999·The Journal of Clinical Investigation·S MakinoS Ogawa
Apr 2, 1999·Science·M F PittengerD R Marshak
May 4, 1999·The Journal of Clinical Investigation·J M Isner, T Asahara
Sep 11, 1999·The American Journal of Cardiology·D MukherjeeS G Ellis
Nov 26, 1999·Circulation·S Oparil
Jan 5, 2000·The Journal of Clinical Investigation·Y LinR P Hebbel
Mar 10, 2000·Science·T ChengD T Scadden
Mar 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·C KalkaT Asahara
Feb 24, 2001·Lancet·P MenaschéJ P Marolleau
Apr 5, 2001·Nature·D OrlicP Anversa
Apr 28, 2001·The Journal of Thoracic and Cardiovascular Surgery·R D WeiselT M Yau
Apr 28, 2001·The Journal of Thoracic and Cardiovascular Surgery·C RajnochA Carpentier
Jun 9, 2001·The New England Journal of Medicine·A P BeltramiP Anversa
Aug 15, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·J D HosenpudR J Novick
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·D OrlicP Anversa
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·G CondorelliG Cossu
Oct 3, 2001·The Journal of Thoracic and Cardiovascular Surgery·J S WangR C Chiu
Oct 17, 2001·Heart·R Von Harsdorf
Jan 5, 2002·The New England Journal of Medicine·Federico QuainiPiero Anversa
Jan 25, 2002·Annals of the New York Academy of Sciences·T Nagasawa

❮ Previous
Next ❯

Citations

Sep 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Eduardo A SilvaDavid J Mooney
Mar 9, 2007·Artificial Organs·Paul S Malchesky
Apr 14, 2012·Journal of Biomedicine & Biotechnology·Chien-Wen ChenJohnny Huard
Mar 26, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Ahmet Ruchan AkarCagdas Baran
Feb 24, 2009·Canadian Journal of Physiology and Pharmacology·Zeynep Tokcaer-KeskinKamil C Akcali
Mar 8, 2012·Canadian Journal of Physiology and Pharmacology·Serkan DurduAhmet Ruchan Akar
Jun 19, 2007·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Ender SoydanMutlu Arat
Jan 11, 2014·Biotechnology Advances·Janani RadhakrishnanSwaminathan Sethuraman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.